Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $nbi

Neurocrine Biosciences' product sales are outperforming competitors like CRMD, TGTX, AXSM, and TARS, yet the company trades at a fraction of their market cap. This disconnect is prompting discussions about valuation and market perception.

### About $nbi
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine-related diseases.  

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$nbi/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$nbi/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXXXXX +43%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXX +381%  
1-Year High: XXXXX on 2025-10-04  
1-Year Low: X on 2025-09-23  

Engagements by network (24h):
X: XXX

  
  
### Mentions: X (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$nbi/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$nbi/time-series/posts_active.tsv)  
Current Value: X  
Daily Average: X  
X Week: XX -XX%  
X Month: XX +113%  
X Months: XXX -XXXX%  
X Year: XXX +159%  
1-Year High: XX on 2025-11-20  
1-Year Low: X on 2025-01-26  

Mentions by network (24h):
X: XX

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$nbi/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$nbi/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $nbi in the last XX hours which is no change from in the previous XX hours
Daily Average: X  
X Week: X -XX%  
X Month: XX +73%  
X Months: XX -X%  
X Year: XX +33%  
1-Year High: XX on 2025-11-20  
1-Year Low: X on 2024-12-11  

The most influential creators that mention $nbi in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X    | XXXXX     | X     | XXX         |

[View More](/list/creators/$nbi/100)

### Top $nbi Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$CRMD DefenCath product sales by quarter post launch v the same from $TGTX $AXSM $ARQT & $TARS CRMD is outselling all X but trades at a fraction of all X market cap This is not to bash the X but to understand the disconnect. Sincere guidance appreciated $XBI $IBB $NBI $IBBQ"  
[X Link](https://x.com/NightOwlBiotech/status/1989085635223879847) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2025-11-13T21:39Z 1666 followers, 3737 engagements


"$DAWN Ojemda US product sales by quarter post launch v $CTIC & $ZGNX who were both acquired for enterprise values of $1.7B This is not investment advice. $NBI $XBI $IBB"  
[X Link](https://x.com/NightOwlBiotech/status/1986124639760712180) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2025-11-05T17:33Z 1666 followers, 1573 engagements


"Updated $SNDX valuation v. actual US product sales compared to peers that exited via M&A & those still independent. $ARQT $AVDL $AXSM $TGTX may not be truly apples to apples. This is not investment advice. We're merely sharing X valuation perspective $XBI $IBB $IBBQ $NBI"  
[X Link](https://x.com/NightOwlBiotech/status/1985481633172959270) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2025-11-03T22:58Z 1663 followers, 1439 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$nbi

Neurocrine Biosciences' product sales are outperforming competitors like CRMD, TGTX, AXSM, and TARS, yet the company trades at a fraction of their market cap. This disconnect is prompting discussions about valuation and market perception.

About $nbi

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine-related diseases.

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXXX +43%
X Months: XXXXXXX -XX%
X Year: XXXXXXX +381%
1-Year High: XXXXX on 2025-10-04
1-Year Low: X on 2025-09-23

Engagements by network (24h): X: XXX

Mentions: X (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
X Week: XX -XX%
X Month: XX +113%
X Months: XXX -XXXX%
X Year: XXX +159%
1-Year High: XX on 2025-11-20
1-Year Low: X on 2025-01-26

Mentions by network (24h): X: XX

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $nbi in the last XX hours which is no change from in the previous XX hours Daily Average: X
X Week: X -XX%
X Month: XX +73%
X Months: XX -X%
X Year: XX +33%
1-Year High: XX on 2025-11-20
1-Year Low: X on 2024-12-11

The most influential creators that mention $nbi in the last XX hours

Creator Rank Followers Posts Engagements
@NightOwlBiotech X XXXXX X XXX

View More

Top $nbi Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$CRMD DefenCath product sales by quarter post launch v the same from $TGTX $AXSM $ARQT & $TARS CRMD is outselling all X but trades at a fraction of all X market cap This is not to bash the X but to understand the disconnect. Sincere guidance appreciated $XBI $IBB $NBI $IBBQ"
X Link @NightOwlBiotech 2025-11-13T21:39Z 1666 followers, 3737 engagements

"$DAWN Ojemda US product sales by quarter post launch v $CTIC & $ZGNX who were both acquired for enterprise values of $1.7B This is not investment advice. $NBI $XBI $IBB"
X Link @NightOwlBiotech 2025-11-05T17:33Z 1666 followers, 1573 engagements

"Updated $SNDX valuation v. actual US product sales compared to peers that exited via M&A & those still independent. $ARQT $AVDL $AXSM $TGTX may not be truly apples to apples. This is not investment advice. We're merely sharing X valuation perspective $XBI $IBB $IBBQ $NBI"
X Link @NightOwlBiotech 2025-11-03T22:58Z 1663 followers, 1439 engagements

$nbi
/topic/$nbi